Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain

Seminars in Cancer Biology

Volumn 18, Issue 3, 2008, Pages 150-163

  Mravec, Boris ^a,b   Gidron, Yori ^c   Hulin, Ivan ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

Cholinergic anti inflammatory pathway; Innervation of the tumors; Neurobiology of cancer; Neurotransmitters; Vagus nerve

Indexed keywords

BRAIN FUNCTION; BRAIN TUMOR; CANCER CELL; CANCER INCIDENCE; CANCER PATIENT; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CLINICAL PATHWAY; CLINICAL STUDY; DIAGNOSTIC PROCEDURE; ENDOCRINE SYSTEM; EXPERIMENTAL STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMOR; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MONITORING; NERVE CELL; NERVE FIBER; NERVE MEMBRANE; NERVOUS SYSTEM; NEUROBIOLOGY; NEUROMUSCULAR TRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SIGNAL TRANSDUCTION; SOCIAL PSYCHOLOGY; TUMOR GROWTH;

ANIMALS; BRAIN; CELL TRANSFORMATION, NEOPLASTIC; ENDOCRINE SYSTEM; HUMANS; IMMUNE SYSTEM; NEURONS; RISK FACTORS;

EID: 42649138860     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.12.002     Document Type: Review

References (189)

1. Besedovsky H.O., and Rey A.D. Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 21 (2007) 34-44
2. Razavi R., Chan Y., Afifiyan F.N., Liu X.J., Wan X., Yantha J., et al. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 127 (2006) 1123-1135
3. Gidron Y., Kupper N., Kwaijtaal M., Winter J., and Denollet J. Vagus-brain communication in atherosclerosis-related inflammation: a neuroimmunomodulation perspective of CAD. Atherosclerosis 195 (2007) 1-9
4. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007) 289-296
5. Mareel M., and Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83 (2003) 337-376
6. Balkwill F., and Coussens L.M. Cancer: an inflammatory link. Nature 431 (2004) 405-406
7. de Visser K.E., Eichten A., and Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6 (2006) 24-37
8. Prolo P., Chiappelli F., Bernard G., Fiala M., Ibarra A., Sartori M.L., et al. Neuroendocrine-immune surveillance of osteosarcoma: emerging hypothesis. J Dent Res 82 (2003) 417-421
9. Gidron Y., Perry H., and Glennie M. Does the vagus nerve inform the brain about preclinical tumours and modulate them?. Lancet Oncol 6 (2005) 245-248
10. Esteban F., Munoz M., Gonzalez-Moles M.A., and Rosso M. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev 25 (2006) 137-145
11. Mravec B., and Hulin I. Does vagus nerve constitute a self-organization complexity or a "hidden network"?. Bratisl Lek Listy 107 (2006) 3-8
12. Mravec B., Gidron Y., Kukanova B., Bizik J., Kiss A., and Hulin I. Neural-endocrine-immune complex in the central modulation of tumorigenesis: facts, assumptions, and hypotheses. J Neuroimmunol 180 (2006) 104-116
13. Serafeim A., and Gordon J. The immune system gets nervous. Curr Opin Pharmacol 1 (2001) 398-403
14. Blalock J.E. The immune system as the sixth sense. J Intern Med 257 (2005) 126-138
15. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., and Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115 (2005) 289-295
16. Ferencik M., and Stvrtinova V. Is the immune system our sixth sense? Relation between the immune and neuroendocrine systems. Bratisl Lek Listy 98 (1997) 187-198
17. Blalock J.E., and Smith E.M. Conceptual development of the immune system as a sixth sense. Brain Behav Immun 21 (2007) 23-33
18. Berczi I., Chow D.A., Baral E., and Nagy E. Neuroimmunoregulation and cancer (review). Int J Oncol 13 (1998) 1049-1060
19. Entschladen F., Drell IV T.L., Lang K., Joseph J., and Zaenker K.S. Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis development. Curr Pharm Des 11 (2005) 403-411
20. Lang K., and Bastian P. Neurotransmitter effects on tumor cells and leukocytes. Prog Exp Tumor Res 39 (2007) 99-121
21. Conti A. Oncology in neuroimmunomodulation. What progress has been made?. Ann NY Acad Sci 917 (2000) 68-83
22. Erin N., Boyer P.J., Bonneau R.H., Clawson G.A., and Welch D.R. Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Res 24 (2004) 1003-1009
23. Watt P.C., Patterson C.C., and Kennedy T.L. Late mortality after vagotomy and drainage for duodenal ulcer. Br Med J (Clin Res Ed) 288 (1984) 1335-1338
24. Caygill C.P., Hill M.J., Kirkham J.S., and Northfield T.C. Mortality from colorectal and breast cancer in gastric-surgery patients. Int J Colorectal Dis 3 (1988) 144-148
25. Caygill C.P., Knowles R.L., and Hall R. Increased risk of cancer mortality after vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev 1 (1991) 35-37
26. Ekbom A., Lundegardh G., McLaughlin J.K., and Nyren O. Relation of vagotomy to subsequent risk of lung cancer: population based cohort study. BMJ 316 (1998) 518-519
27. Nelson R.L., Briley S., Vaz O.P., and Abcarian H. The effect of vagotomy and pyloroplasty on colorectal tumor induction in the rat. J Surg Oncol 51 (1992) 281-286
28. Caygill C.P., Hill M.J., Kirkham J.S., and Northfield T.C. Oesophageal cancer in gastric surgery patients. Ital J Gastroenterol 25 (1993) 168-170
29. Fisher S.G., Davis F., Nelson R., Weber L., and Haenszel W. Large bowel cancer following gastric surgery for benign disease: a cohort study. Am J Epidemiol 139 (1994) 684-692
30. Lundegardh G., Ekbom A., McLaughlin J.K., and Nyren O. Gastric cancer risk after vagotomy. Gut 35 (1994) 946-949
31. Bayon L.A.M., Landa G.I., Alcalde E.J., Rodriguez D.S., Ortega M.L., and Balibrea C.J.L. Colonic carcinogenesis in vagotomyzed rats. Rev Esp Enferm Dig 93 (2001) 576-586
32. Bahmanyar S., Ye W., Dickman P.W., and Nyren O. Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer. Am J Gastroenterol 102 (2007) 1185-1191
33. Jenkins J.T., Duncan J.R., Hole D., O'dwyer P.J., and McGregor J.R. Malignant disease in peptic ulcer surgery patients after long term follow-up: a cohort study of 1992 patients. Eur J Surg Oncol 33 (2007) 706-712
34. Erin N., Zhao W., Bylander J., Chase G., and Clawson G. Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells. Breast Cancer Res Treat 99 (2006) 351-364
35. Hodgson D.M., Yirmiya R., Chiappelli F., and Taylor A.N. Intracerebral HIV glycoprotein (gp120) enhances tumor metastasis via centrally released interleukin-1. Brain Res 781 (1998) 244-251
36. Hodgson D.M., Yirmiya R., Chiappelli F., and Taylor A.N. Intracerebral interleukin-1beta impairs response to tumor invasion: involvement of adrenal catecholamines. Brain Res 816 (1999) 200-208
37. Hodgson D.M., Yirmiya R., and Taylor A.N. Intracerebroventricular interleukin-1beta impairs clearance of tumor cells from the lungs: role of brain prostaglandins. J Neuroimmunol 119 (2001) 57-63
38. Leo N.A., and Bonneau R.H. Chemical sympathectomy alters cytotoxic T lymphocyte responses to herpes simplex virus infection. Ann N Y Acad Sci 917 (2000) 923-934
39. Tatsuta M., Iishi H., Baba M., and Taniguchi H. Inhibition of azoxymethane-induced experimental colon carcinogenesis in Wistar rats by 6-hydroxydopamine. Int J Cancer 50 (1992) 298-301
40. Sood A.K., Bhatty R., Kamat A.A., Landen C.N., Han L., Thaker P.H., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12 (2006) 369-375
41. Yang E.V., Sood A.K., Chen M., Li Y., Eubank T.D., Marsh C.B., et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66 (2006) 10357-10364
42. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol 172 (2006) 38-58
43. Callaghan B.D. Does the pineal gland have a role in the psychological mechanisms involved in the progression of cancer?. Med Hypotheses 59 (2002) 302-311
44. Kergozien S., Delcros J.G., Jouan H., and Moulinoux J.P. Induction of Fos protein expression in spinal cord neurons of tumour-bearing rats. Br J Cancer 80 (1999) 1512-1517
45. Konsman J.P., and Blomqvist A. Forebrain patterns of c-Fos and FosB induction during cancer-associated anorexia-cachexia in rat. Eur J Neurosci 21 (2005) 2752-2766
46. Hollis J.H., Lightman S.L., and Lowry C.A. Integration of systemic and visceral sensory information by medullary catecholaminergic systems during peripheral inflammation. Ann N Y Acad Sci 1018 (2004) 71-75
47. Tashiro M., Kubota K., Itoh M., Yoshioka T., Yoshida M., Nakagawa Y., et al. Hypometabolism in the limbic system of cancer patients observed by positron emission tomography. Psychooncology 8 (1999) 283-286
48. Tashiro M., Itoh M., Kubota K., Kumano H., Masud M.M., Moser E., et al. Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: a preliminary PET study. Psychooncology 10 (2001) 541-546
49. Watson M., Haviland J.S., Greer S., Davidson J., and Bliss J.M. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354 (1999) 1331-1336
50. Spiegel D., and Kato P.M. Psychosocial influences on cancer incidence and progression. Harv Rev Psychiatry 4 (1996) 10-26
51. Kiecolt-Glaser J.K., and Glaser R. Psychoneuroimmunology and cancer: fact or fiction?. Eur J Cancer 35 (1999) 1603-1607
52. Petticrew M., Bell R., and Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 325 (2002) 1066
53. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 109 (1996) 16
54. Spiegel D. Embodying the mind in psychooncology research. Adv Mind Body Med 15 (1999) 267-273
55. Reiche E.M., Morimoto H.K., and Nunes S.M. Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 17 (2005) 515-527
56. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6 (2006) 240-248
57. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., and Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8 (2000) 154-164
58. Maier S.F., and Watkins L.R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695 (1995) 279-282
59. Voronov E., Shouval D.S., Krelin Y., Cagnano E., Benharroch D., Iwakura Y., et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100 (2003) 2645-2650
60. Argaman M., Gidron Y., and Ariad S. Interleukin-1 may link helplessness-hopelessness with cancer progression: a proposed model. Int J Behav Med 12 (2005) 161-170
61. Sephton S., and Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?. Brain Behav Immun 17 (2003) 321-328
62. Heffner K.L., Loving T.J., Robles T.F., and Kiecolt-Glaser J.K. Examining psychosocial factors related to cancer incidence and progression: in search of the silver lining. Brain Behav Immun 17 (2003) 109-111
63. Gidron Y., Russ K., Tissarchondou H., and Warner J. The relation between psychological factors and DNA-damage: a critical review. Biol Psychol 72 (2006) 291-304
64. Dantzer R., Konsman J.P., Bluthe R.M., and Kelley K.W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?. Auton Neurosci 85 (2000) 60-65
65. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., and Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci 85 (2000) 49-59
66. Pavlov V.A., Wang H., Czura C.J., Friedman S.G., and Tracey K.J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9 (2003) 125-134
67. Sternberg E.M. Neural-immune interactions in health and disease. J Clin Invest 100 (1997) 2641-2647
68. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 20 (1999) 254-257
69. Rothwell N.J., and Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 18 (1995) 130-136
70. Quan N., and Herkenham M. Connecting cytokines and brain: a review of current issues. Histol Histopathol 17 (2002) 273-288
71. Turrin N.P., and Rivest S. Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems. Exp Biol Med 229 (2004) 996-1006
72. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 57 (1995) 1011-1026
73. Nadeau S., and Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93 (1999) 1449-1464
74. Szelenyi J. Cytokines and the central nervous system. Brain Res Bull 54 (2001) 329-338
75. Konsman J.P., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25 (2002) 154-159
76. Turnbull A.V., and Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79 (1999) 1-71
77. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26 (2001) 761-788
78. Savino W., and Dardenne M. Immune-neuroendocrine interactions. Immunol Today 16 (1995) 318-322
79. Petrovsky N. Towards a unified model of neuroendocrine-immune interaction. Immunol Cell Biol 79 (2001) 350-357
80. Shepherd A.J., Downing J.E., and Miyan J.A. Without nerves, immunology remains incomplete-in vivo veritas. Immunology 116 (2005) 145-163
81. Blalock J.E. The syntax of immune-neuroendocrine communication. Immunol Today 15 (1994) 504-511
82. Smith R.S., Smith T.J., Blieden T.M., and Phipps R.P. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151 (1997) 317-322
83. Buckley C.D., Pilling D., Lord J.M., Akbar A.N., Scheel-Toellner D., and Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 22 (2001) 199-204
84. Kaufman J., Graf B.A., Leung E.C., Pollock S.J., Koumas L., Reddy S.Y., et al. Fibroblasts as sentinel cells: role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation and fibrosis. Chest 120 (2001) S53-S55
85. Paintal A.S. Vagal sensory receptors and their reflex effects. Physiol Rev 53 (1973) 159-227
86. Romanovsky A.A., Ivanov A.I., and Szekely M. Neural route of pyrogen signaling to the brain. Clin Infect Dis 31 (2000) S162-S167
87. Ek M., Kurosawa M., Lundeberg T., and Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 18 (1998) 9471-9479
88. Maier S.F., Goehler L.E., Fleshner M., and Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 840 (1998) 289-300
89. Perry V.H. The impact of systemic inflammation on brain inflammation. ACNR 4 (2004) 8-9
90. Goehler L.E., Gaykema R.P., Hammack S.E., Maier S.F., and Watkins L.R. Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res 804 (1998) 306-310
91. Hansen M.K., Daniels S., Goehler L.E., Gaykema R.P., Maier S.F., and Watkins L.R. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton Neurosci 85 (2000) 83-87
92. Licinio J., and Wong M.L. Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 100 (1997) 2941-2947
93. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., et al. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 43 (1997) 357-364
94. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., et al. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J Neurosci 19 (1999) 2799-2806
95. Roth J., and De Souza G.E. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res 34 (2001) 301-314
96. Hermann G.E., Holmes G.M., and Rogers R.C. TNF(alpha) modulation of visceral and spinal sensory processing. Curr Pharm 11 (2005) 1391-1409
97. Rook G.A., Lightman S.L., and Heijnen C.J. Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends Immunol 23 (2002) 18-22
98. Ito N., DeMarco R.A., Mailliard R.B., Han J., Rabinowich H., Kalinski P., et al. Cytolytic cells induce HMGB1 release from melanoma cell lines. J Leukoc Biol 81 (2007) 75-83
99. Ramos E.J., Suzuki S., Marks D., Inui A., Asakawa A., and Meguid M.M. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7 (2004) 427-434
100. Bernstein I.L. Neutral mediation of food aversions and anorexia induced by tumor necrosis factor and tumors. Neurosci Biobehav Rev 20 (1996) 177-181
101. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58 (2001) 445-452
102. Illman J., Corringham R., Robinson Jr. D., Davis H.M., Rossi J.F., Cella D., et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression?. J Support Oncol 3 (2005) 37-50
103. Roberts J.E. Light and immunomodulation. Ann N Y Acad Sci 917 (2000) 435-445
104. Filipski E., King V.M., Li X., Granda T.G., Mormont M.C., Liu X., et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94 (2002) 690-697
105. Brzezinski A. Melatonin in humans. N Engl J Med 336 (1997) 186-195
106. Berczi I. Neuroimmune biology-an introduction. In: Berczi I., and Gorezynski R.M. (Eds). New foundation of biology (2001), Elsevier Science, Amsterdam 3-45
107. Brogden K.A., Guthmiller J.M., Salzet M., and Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 6 (2005) 558-564
108. Broome C.S., and Miyan J.A. Neuropeptide control of bone marrow neutrophil production. A key axis for neuroimmunomodulation. Ann N Y Acad Sci 917 (2000) 424-434
109. Maestroni G.J. Neurohormones and catecholamines as functional components of the bone marrow microenvironment. Ann N Y Acad Sci 917 (2000) 29-37
110. Berczi I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation 1 (1994) 201-216
111. Berczi I. Pituitary hormones and immune function. Acta Paediatr 423 (1997) 70-75
112. Fabris N., Mocchegiani E., and Provinciali M. Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction. Horm Res 43 (1995) 29-38
113. Vamvakopoulos N.C., and Chrousos G.P. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev 15 (1994) 409-420
114. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 161 (1998) 2873-2880
115. Ichiyama T., Sato S., Okada K., Catania A., and Lipton J.M. The neuroimmunomodulatory peptide alpha-MSH. Ann N Y Acad Sci 917 (2000) 221-226
116. Almawi W.Y., Melemedjian O.K., and Rieder M.J. An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant 13 (1999) 365-374
117. Yang H., Wang L., and Ju G. Evidence for hypothalamic paraventricular nucleus as an integrative center of neuroimmunomodulation. Neuroimmunomodulation 4 (1997) 120-127
118. Cassoni P., Sapino A., Marrocco T., Chini B., and Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J Neuroendocrinol 16 (2004) 362-364
119. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., and Gale R.P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 5 (1991) 193-205
120. Inagaki A., Ishida T., Ishii T., Komatsu H., Iida S., Ding J., et al. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Int J Cancer 118 (2006) 3054-3061
121. Dardenne M., and Savino W. Control of thymus physiology by peptidic hormones and neuropeptides. Immunol Today 15 (1994) 518-523
122. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (2000) 595-638
123. Czura C.J., and Tracey K.J. Autonomic neural regulation of immunity. J Intern Med 257 (2005) 156-166
124. Nance D.M., and Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21 (2007) 736-745
125. Weigent D.A., and Blalock J.E. Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev 100 (1987) 79-108
126. Stevens-Felten S.Y., and Bellinger D.L. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 69 (1997) 99-131
127. Basu S., and Dasgupta P.S. Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 102 (2000) 113-124
128. Denes A., Boldogkoi Z., Uhereczky G., Hornyak A., Rusvai M., Palkovits M., et al. Central autonomic control of the bone marrow: multisynaptic tract tracing by recombinant pseudorabies virus. Neuroscience 134 (2005) 947-963
129. Elenkov I.J., Hasko G., Kovacs K.J., and Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol 61 (1995) 123-131
130. Vizi E.S., Orso E., Osipenko O.N., Hasko G., and Elenkov I.J. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68 (1995) 1263-1276
131. Hasko G., and Szabo C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol 56 (1998) 1079-1087
132. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
133. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124 (2006) 407-421
134. Vizi E.S. Receptor-mediated local fine-tuning by noradrenergic innervation of neuroendocrine and immune systems. Ann N Y Acad Sci 851 (1998) 388-396
135. Borovikova L.V., Ivanova S., Nardi D., Zhang M., Yang H., Ombrellino M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
136. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 195 (2002) 781-788
137. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
138. Rinner I., Felsner P., Liebmann P.M., Hofer D., Wolfler A., Globerson A., et al. Adrenergic/cholinergic immunomodulation in the rat model-in vivo veritas?. Dev Immunol 6 (1998) 245-252
139. Kawashima K., and Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci 72 (2003) 2101-2109
140. Qiu Y.H., Peng Y.P., Jiang J.M., and Wang J.J. Expression of tyrosine hydroxylase in lymphocytes and effect of endogenous catecholamines on lymphocyte function. Neuroimmunomodulation 11 (2004) 75-83
141. Kowalska K., Carr D.B., and Lipkowski A.W. Direct antimicrobial properties of substance P. Life Sci 71 (2002) 747-750
142. Metz-Boutigue M.H., Goumon Y., Strub J.M., Lugardon K., and Aunis D. Antimicrobial chromogranins and proenkephalin-A-derived peptides: Antibacterial and antifungal activities of chromogranins and proenkephalin-A-derived peptides. Ann N Y Acad Sci 992 (2003) 168-178
143. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24 (2003) 389-427
144. Heasley L.E. Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 20 (2001) 1563-1569
145. Schuller H.M. Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res 39 (2007) 45-63
146. Drell IV T.L., Joseph J., Lang K., Niggemann B., Zaenker K.S., and Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 80 (2003) 63-70
147. Zukowska Z., Grant D.S., and Lee E.W. Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 13 (2003) 86-92
148. Lang K., Drell IV T.L., Lindecke A., Niggemann B., Kaltschmidt C., Zaenker K.S., et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112 (2004) 231-238
149. Serafeim A., Grafton G., Chamba A., Gregory C.D., Blakely R.D., Bowery N.G., et al. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99 (2002) 2545-2553
150. Tarr J.M., Eggleton P., and Winyard P.G. Nitric oxide and the regulation of apoptosis in tumour cells. Curr Pharm Des 12 (2006) 4445-4468
151. Legat F.J., and Wolf P. Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin?. Photochem Photobiol Sci 5 (2006) 170-176
152. Joseph J., Niggemann B., Zaenker K.S., and Entschladen F. The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res 62 (2002) 6467-6469
153. Joseph J., Niggemann B., Zaenker K.S., and Entschladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 53 (2004) 723-728
154. Giannoulia-Karantana A., Vlachou A., Polychronopoulou S., Papassotiriou I., and Chrousos G.P. Melatonin and immunomodulation: connections and potential clinical applications. Neuroimmunomodulation 13 (2006) 133-144
155. Kajdaniuk D., Marek B., Kos-Kudła B., Ciesielska-Kopacz N., and Buntner B. Oncostatic effect of melatonin action-facts and hypotheses. Med Sci Monit 5 (1999) RA350-RA356
156. Heinrichs M., Baumgartner T., Kirschbaum C., and Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54 (2003) 1389-1398
157. Soler-Vila H., Kasl S.V., and Jones B.A. Prognostic significance of psychosocial factors in African-American and white breast cancer patients: a population-based study. Cancer 98 (2003) 1299-1308
158. Russo P., Catassi A., Cesario A., and Servent D. Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system. Curr Med Chem 13 (2006) 3493-3512
159. Vachkov I.H., Huang X., Yamada Y., Tonchev A.B., Yamashima T., Kato S., et al. Inhibition of axonal outgrowth in the tumor environment: involvement of class 3 semaphorins. Cancer Sci 98 (2007) 1192-1197
160. Seifert P., and Spitznas M. Tumours may be innervated. Virchows Arch 438 (2001) 228-231
161. Seifert P., Benedic M., and Effert P. Nerve fibers in tumors of the human urinary bladder. Virchows Arch 440 (2002) 291-297
162. Palm D., and Entschladen F. Neoneurogenesis and the neuro-neoplastic synapse. Prog Exp Tumor Res 39 (2007) 91-98
163. Zanker K.S. The neuro-neoplastic synapse: does it exist?. Prog Exp Tumor Res 39 (2007) 154-161
164. Entschladen F., Palm D., Lang K., Drell IV T.L., and Zaenker K.S. Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med Hypotheses 67 (2006) 33-35
165. Lang K., Entschladen F., Weidt C., and Zaenker K.S. Tumor immune escape mechanisms: impact of the neuroendocrine system. Cancer Immunol Immunother 55 (2006) 749-760
166. Muller J.M. Potential inhibition of the neuro-neoplastic interactions: the clue of a GPCR-targeted therapy. Prog Exp Tumor Res 39 (2007) 130-153
167. Houghton J., Morozov A., Smirnova I., and Wang T.C. Stem cells and cancer. Semin Cancer Biol 17 (2007) 191-203
168. Li Q., Withoff S., and Verma I.M. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26 (2005) 318-325
169. Maeda A., Ebata T., Matsunaga K., Kanemoto H., Bando E., Yamaguchi S., et al. Primary liver cancer with bidirectional differentiation into hepatocytes and biliary epithelium. J Hepatobiliary Pancreat Surg 12 (2005) 484-487
170. Gallowitsch-Puerta M., and Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 80 (2007) 2325-2329
171. Borovikova L.V., Ivanova S., Nardi D., Zhang M., Yang H., Ombrellino M., et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 85 (2000) 141-147
172. Atkins M.B., Redman B., Mier J., Gollob J., Weber J., Sosman J., et al. A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. Clin Cancer Res 7 (2001) 486-492
173. Guarini S., Cainazzo M.M., Giuliani D., Mioni C., Altavilla D., Marini H., et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 63 (2004) 357-365
174. Shiff S.J., Shivaprasad P., and Santini D.L. Cyclooxygenase inhibitors: drugs for cancer prevention. Curr Opin Pharmacol 3 (2003) 352-361
175. Catania A., Arnold J., Macaluso A., Hiltz M.E., and Lipton J.M. Inhibition of acute inflammation in the periphery by central action of salicylates. Proc Natl Acad Sci USA 88 (1991) 8544-8547
176. Deans C., and Wigmore S.J. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8 (2005) 265-269
177. Shanks N., and Lightman S.L. The maternal-neonatal neuro-immune interface: are there long-term implications for inflammatory or stress-related disease?. J Clin Invest 108 (2001) 1567-1573
178. Janszky I., Ericson M., Lekander M., Blom M., Buhlin K., Georgiades A., et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 256 (2004) 421-428
179. Waldmann T.A. Effective cancer therapy through immunomodulation. Annu Rev Med 57 (2006) 65-81
180. Abo T., and Kawamura T. Immunomodulation by the autonomic nervous system: therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases. Ther Apher 6 (2002) 348-357
181. Davidson R.J., Coe C.C., Dolski I., and Donzella B. Individual differences in prefrontal activation asymmetry predict natural killer cell activity at rest and in response to challenge. Brain Behav Immun 2 (1999) 93-108
182. Bernardi L., Sleight P., Bandinelli G., Cencetti S., Fattorini L., Wdowczyc-Szulc J., et al. Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. BMJ 323 (2001) 1446-1449
183. Infante J.R., Torres-Avisbal M., Pinel P., Vallejo J.A., Peran F., Gonzalez F., et al. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav 72 (2001) 141-146
184. Gruber B.L., Hersh S.P., Hall N.R., Waletzky L.R., Kunz J.F., Carpenter J.K., et al. Immunological responses of breast cancer patients to behavioral interventions. Biofeedback Self Regul 18 (1993) 1-22
185. Bakke A.C., Purtzer M.Z., and Newton P. The effect of hypnotic-guided imagery on psychological well-being and immune function in patients with prior breast cancer. J Psychosom Res 53 (2002) 1131-1137
186. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2 (2002) 210-219
187. Silzle T., Randolph G.J., Kreutz M., and Kunz-Schughart L.A. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 108 (2004) 173-180
188. Tlsty T.D., and Hein P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11 (2001) 54-59
189. Straub R.H., Westermann J., Scholmerich J., and Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 19 (1998) 409-413